William Hait, MD, PhD

Dr. Hait is responsible for driving the transformational innovations that help Johnson & Johnson improve human health. He also oversees the Research and Development Management Committee that focuses on talent development and best-practice sharing within the Company’s Research & Development Community. Dr. Hait is passionate about leading Company efforts to improve healthcare for the world’s most vulnerable and underserved populations, and meet its obligations around product safety and ethical research. Dr. Hait joined Johnson & Johnson in 2007 and served as Global Therapeutic Area Head for Oncology from 2009 to 2011, and then as Global Head, Janssen Research & Development, from 2011 through 2018. Under his leadership, the company launched more than 20 new products, transforming the lives of millions of people around the world.

Before joining Johnson & Johnson, Dr. Hait was the founding Director of the (Rutgers) Cancer Institute of New Jersey. From 1993 to 2007, he was a Professor of Medicine and Pharmacology and Associate Dean for Oncology Programs at the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School.

Dr. Hait received his Ph.D. and Doctorate of Medicine cum Laude from the Medical College of Pennsylvania and received house staff and fellowship training at the Yale New Haven Hospital. He is Board certified in Internal Medicine and Medical Oncology and served as Chief of the Division of Medical Oncology at the Yale University School of Medicine.